We help disease foundations and life sciences researchers improve fundraising by clarifying and increasing research impact.
Design and guidance of strategic plans and consortium projects.
Unparalleled Expertise
Scott Wagers is a physician, and translational researcher turned consultant, an unmatched blend of scientific, clinical and commercial perspectives.
Banking on over 17 years of experience, Scott brings invaluable insights from over 60 consortium projects spread across multiple domains and disciplines.
As a result of Scott's extensive experience, he possesses the ability to expedite the process of consortium project and strategy development.
Moreover, his unique perspective enables him to establish meaningful connections between different concepts and individuals, fostering innovative and collaborative approaches.
Expert Facilitation
An external facilitator has the freedom to ask challenging questions, stimulate unspoken ideas, and explore alternative viewpoints.
They can play the role of a devil’s advocate without being constrained by internal politics, fostering bigger and bolder thinking in strategy meetings.
Scott is a skilled meeting facilitator who brings an impact oriented perspective to the process of consortium project and strategy development.
As an expert external facilitator with a depth knowledge, Scott can help you to tap into the creativity of your team, consortium partners, and stakeholders.
Your Architect for Consortium Project Success
Scott functions as your consortium project architect - facilitating the development of a robust concept that blends your ideas into an impact oriented, compelling design.
A compelling design must be convincingly communicated. Scott supports the proposal writing process as both an advisor and a writer.
Consortium project design is an iterative and continual process. Scott serves as a strategic guide for high profile consortium projects helping them deliver to their full potential.
Its never too early to start working on your next consortium project.
Here are some of the more than 60 consortium
projects that we have supported:
-
This project is developing a range of tools that will enhance the ability to assess the ability to predict the safety of immunomodulatory therapies. BioSci Consulting supported the development of the proposal where the concept of using immune related Adverse Outcome Pathways as a framework for structuring both the knowledge and the experimental work of the project. As a partner BioSci Consulting is working to build a stakeholder community and establish a sustainability model centered around the use of irAOPs.
-
.. from industry. U-BIOPRED is a public private partnership that focused on integrated multiple types of omic profiling data with clinical measurements, patient reported outcomes, and preclinical research to better understand and subclassify severe asthma. Hailed as a flagship of the IMI resulting in 81 publications and a dataset that continues now 13 years after originally funded to be used for research and to make data-driven decisions in the drug development process. U-BIOPRED was also groundbreaking for its meaningful engagement of patient stakeholders. Development of a proposal for long term funding that is suitable for a full submission to a granting agency such as Horizon Europe. This is based upon having a two stage proposal. The different units of work can also be assembled into efforts for smaller proposals such as to individual pharma companies or as a distributed application to various local funding organisations. This was BioSci Consulting’s first major project and our founder Scott Wagers was involved in the earliest meetings where the concept of developing a ‘handprint’ of severe asthma was conceived.
-
..innovation ecosystem that will accelerate the development of engineered T-cell therapies in the EU. It is a multi-stakeholder project that is developing new safety and efficacy preclinical models, analytical measurements, lymphdepletion regimens, and documentation with the engagement of patient stakeholders and regulators. BioSci Consulting supported the development of proposal using our innovation design process. As a partner in the project BioSci consulting is assuring that the consortium is as cohesive as possible so that it reaches its exponential potential. As such we are leading the effort to develop an exploitation and sustainability model based on the concept of an innovation ecosystem.
-
AIDPATH is focused on building the smart hospital of the future that can carry out de-centralized AI guided cell-therapy manufacturing. BioSci Consulting helped to frame the proposal in an innovation context during the proposal development and is now acting as a consultant to drive consortium cohesiveness and sustainability.
-
This was an emergency project in response to the COVID-19 pandemic. The DRAGON project aims to use AI and machine learning to develop a multi-factorial decision support system to increase the capacity of health systems to manage COVID-19 patients. This project was developed in two and half weeks and the 39% of the consortium partners are SMEs (seven in total). BioSci Consulting supported the intense design sprints that led to a successful proposal and as a partner in the project is building a stakeholder community and a sustainability model centered around development of a learning healthcare system and future pandemic preparedness.
-
P4O2 is building cohorts and basic science experimental campaigns to identify individuals at risk for developing respiratory disease and then designing interventions to prevent the development of respiratory conditions. BioSci Consulting advised on the structure and the IP aspects of the consortium during its development and is now working to build its cohesiveness and realise its exponential potential to become a movement for preventing respiratory disease.
-
BREATH is focused on lung regeneration. BioSci Consulting was also engaged early in the project to promote the cohesiveness and guide the implementation of strategic actions such as the development of a knowledge management strategy
-
AWWA is a project focused on the prevention of a asthma by first understanding the mechanisms of environmental moulding of the immune system and then identifying candidate therapies. BioSci Consulting was engaged shortly after project start to improve consortium cohesiveness and develop a stakeholder community around the prevention of asthma
-
… ADON consortium which then became the respiratory component of the larger 3TR IMI funded project.
Strategy Co-Design
Developing strategy is a process of choosing what to do and what not to do.
Without good strategy you face the risk that resources will be spread too thin or wasted on less impactful activities.
As an external facilitator with broad experience Scott can help bring bolder thinking to the table while avoiding the pitfalls of confirmation bias and groupthink.
Scott also helps involve stakeholders and helps you to communicate your strategy clearly.
Choices you make today determine the likelihood that you will achieve a preferable future.
Based on: Joseph Voros, "A generic Foresight Process Framework” 2003
Beyond Publications Podcast
An interview with Peter J Barnes where we delve into the topics of having a multi-disciplinary team, how to stay motivated, the future of medicine and more.